Salidroside promotes sensitization to doxorubicin in human cancer cells by affecting the PI3K/Akt/HIF signal pathway and inhibiting the expression of tumor-resistance-related proteins - Zeng, Q; Nie, X; Li, L; Liu, H F; Peng, Y Y; Zhou, W T; Hu, X J; Xu, X Y; Chen, X L (J Nat Prod, 2022)